[NEJM] Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia

AndrewCats Post time 6 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-12 12:36
Reward10points

journal:New England Journal of Medicine

Authors:Ravi Savarirayan; Julie Hoover-Fong; Melita Irving; Paul Arundel; Josep Maria de Bergua; Philippe M. Campeau; Toby Candler; Benjamin T. Cocanougher; Valerie Cormier-Daire; Thomas Edouard; Svein O. Fredwall; Paul Harmatz; Daniel Hoernschemeyer; Henrik U. Irgens; Saumya Jamuar; Peter Kannu; Janet M. Legare; Antonio Leiva-Gea; Helen McDevitt; Roberta Onesimo; John Phillips; Mariana del Pino; Marie-Eve Robinson; Massimiliano Rossi; Mars Skae; Leanne M. Ward; Klane K. White; Jane Schmidt; Ted Lystig; Ariana Salvatici; Yun Bai; Peter W. Butler; David van Veenhuyzen; Daniela Rogoff

Published date:2026-9-3

DOI:10.1056/nejmoa2604565

PDF link:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2604565

Article link:https://doi.org/10.1056/nejmoa2604565

Article Source:Massachusetts Medical Society


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 6 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list